US 8809341
2,4-pyrimidinediamine compounds and uses as anti-proliferative agents
granted A61KA61K31/4353A61K31/505
Quick answer
US patent 8809341 (2,4-pyrimidinediamine compounds and uses as anti-proliferative agents) held by Rigel Pharmaceuticals, Inc. expires Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Aug 19 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 14 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K31/4353, A61K31/505, A61K31/506, A61P